Similarly, MSC-based VEGF gene therapy in the rat myocardial infarction model showed that, compared with the control, the VEGF-MSC treatment significantly attenuated left ventricular fibrosis in ischemic myocardium (Moon et al., 2014). The gene discussed is VEGFA; the disease is myocardial infarction.